Ultrasound-guided intercostal block for myofascial pain syndrome
Effectiveness of Serratus Posterior Superior Intercostal Plane Block Applied With Ultrasonography in Myofascial Pain Syndrome
This study is testing a new ultrasound-guided injection method to see if it can help relieve pain for people with Myofascial Pain Syndrome.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06557993 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the effectiveness of the Serratus Posterior Superior Intercostal Plane Block, performed under ultrasonography, in treating Myofascial Pain Syndrome (MAS). The study aims to inactivate trigger points within muscles that cause pain and discomfort, utilizing local anesthetic injections as a primary treatment method. Participants will be monitored for their response to the treatment, with the goal of reducing muscle tension and restoring normal muscle function. The study will include patients aged 18-65 who have been diagnosed with MAS and have not undergone invasive procedures in the last three months.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 diagnosed with myofascial pain syndrome who have not received invasive treatments in the past three months.
Not a fit: Patients who have undergone invasive procedures for myofascial pain syndrome within the last three months may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly alleviate pain and improve muscle function for patients suffering from myofascial pain syndrome.
How similar studies have performed: Other studies have shown promising results with similar ultrasound-guided injection techniques for pain management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between the ages of 18-65 and having been diagnosed with MAS based on the MAS diagnostic criteria, * No invasive procedure has been performed for this disease in the last 3 months * Signing the informed consent form * Patients with complete data to be scanned in their files
Where this trial is running
Istanbul
- Kanuni Sultan Süleyman Training and Research Hospital — Istanbul, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: halil ibrahim altun
- Email: halilibrahim_altun@yahoo.com
- Phone: +905072774773
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.